SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: Value_Investor, dipANDrip
Search This Board: 
Last Post: 12/12/2017 7:02:33 PM - Followers: 70 - Board type: Free - Posts Today: 0

 

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

SureTrader
Interactive Brokers Advertisement
NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
News News Alert: Current Report Filing (8-k) 12/12/2017 05:02:11 PM
PostSubject
#1143  Sticky Note $0.1257 was tested today as I predicted yesterday! Value_Investor 12/11/17 05:15:22 PM
#1147   Nice to see the New high $0.138 today Value_Investor 12/12/17 07:02:32 PM
#1146   $NSPR spinning its tires in share washing mud. Penny Profit Prophet 12/12/17 12:19:49 PM
#1145   It seems no way to break down yesterday's Value_Investor 12/12/17 09:50:27 AM
#1144   NSPR declined to $0.13 first in today's After-Hour Value_Investor 12/11/17 08:14:55 PM
#1143   $0.1257 was tested today as I predicted yesterday! Value_Investor 12/11/17 05:15:22 PM
#1141   No. NSPR will test $0.125 first then it Value_Investor 12/10/17 03:30:31 PM
#1140   Gap up and run - Monday George1234 12/09/17 10:39:40 PM
#1139   0.01301 x 0.1309 last evening! It seems NSPR Value_Investor 12/09/17 05:03:36 PM
#1138   LOL, another bad news just kicked in after Value_Investor 12/08/17 05:36:24 PM
#1137   I think NSPR is still heading onto to Value_Investor 12/08/17 01:56:45 PM
#1136   Next stop, the moon. animebrand 12/08/17 11:05:07 AM
#1135   Last evening NSPR declined to $0.1299! So I Value_Investor 12/08/17 08:42:39 AM
#1134   REBOUND STARTED knrorrel 12/08/17 12:43:12 AM
#1133   $NSPR now rebound 500 %+ maybe ?? WEEEE http://www.nasdaq.com/de/symbol/nspr/ knrorrel 12/08/17 12:41:07 AM
#1132   Today Bad news again? Is $0.125 the real Value_Investor 12/07/17 05:02:57 PM
#1131   * * $NSPR Video Chart 12-07-17 * * ClayTrader 12/07/17 04:56:33 PM
#1130   And then they continue dumping into the news... smh dipANDrip 12/07/17 02:20:25 PM
#1129   Getting some steam, let’s see. notagain1 12/07/17 01:12:35 PM
#1128   Looking like the last round rush @ 17-18. notagain1 12/07/17 01:04:56 PM
#1127   Where are all these shares coming from?? notagain1 12/07/17 12:59:34 PM
#1126   Someone’s do not want this to move up notagain1 12/07/17 12:54:25 PM
#1125   http://www.inspiremd.com/en/press-center/inspiremds-cguard-eps-demonstrates-impr Three2001 12/07/17 12:50:30 PM
#1124   More news out just now about the effectiveness Three2001 12/07/17 12:36:31 PM
#1123   They have till Feb 2019 look over at GordonGeckoJr 12/07/17 09:47:17 AM
#1122   What is the reason for NSPR to be Value_Investor 12/07/17 08:23:48 AM
#1121   Btw a word of caution: if this tikr notagain1 12/07/17 07:01:34 AM
#1120   Just when you think it can’t go any notagain1 12/07/17 06:47:20 AM
#1119   Bro there’s no point in fighting it. I BULLISHBENNETT 12/07/17 05:12:21 AM
#1118   OR MORE 0,5+ BOUNCE HARD http://http://stockcharts.com/h-sc/ui?s=NSPR knrorrel 12/07/17 05:08:43 AM
#1117   AGREEMENT ROCKING NOW UP, EPIC UNDERVALUED knrorrel 12/07/17 01:39:42 AM
#1116   Time to rock and roll here... Motba 12/07/17 12:30:00 AM
#1115   LOL, I wish your pipe dream become true Value_Investor 12/06/17 11:58:15 PM
#1114   Sorry .10 BULLISHBENNETT 12/06/17 11:49:32 PM
#1113   I told you. It won’t stop till .010 BULLISHBENNETT 12/06/17 11:49:13 PM
#1112   NSPR hit a New low $0.125 today! Huge Value_Investor 12/06/17 06:47:42 PM
#1111   Where the heck are all these shares coming Penny Profit Prophet 12/06/17 05:52:24 PM
#1110   * * $NSPR Video Chart 12-06-17 * * ClayTrader 12/06/17 04:19:38 PM
#1108   If you don’t believe me read this 5 BULLISHBENNETT 12/06/17 03:43:05 PM
#1107   100% FALSE! The investors can buy the dirt Value_Investor 12/06/17 02:30:56 PM
#1106   Yes but they won’t if they can get BULLISHBENNETT 12/06/17 12:20:35 PM
#1105   With any good news like yesterday NSPR can Value_Investor 12/06/17 12:03:15 PM
#1104   The big investors will buy at bottom BULLISHBENNETT 12/06/17 12:01:02 PM
#1103   Agreed BULLISHBENNETT 12/06/17 11:59:52 AM
#1102   How ? BULLISHBENNETT 12/06/17 11:59:44 AM
#1101   A Pipe Dream! At $0.1 a couple of Value_Investor 12/06/17 11:59:28 AM
#1100   It will breakout. And yes I want cheaper BULLISHBENNETT 12/06/17 11:59:25 AM
#1099   Very nice bounce bought 14 and sold at BULLISHBENNETT 12/06/17 11:56:49 AM
#1098   Thought we had nice bounce out yesterday when Three2001 12/06/17 11:54:12 AM
#1097   In @ .129 nice reversal on tap for NSPR micromillionaire 12/06/17 11:53:19 AM
#1096   Goin to 10 first BULLISHBENNETT 12/06/17 11:51:59 AM
PostSubject